Plné znění - 2/2008 Sb. m. s.

Ministerstvo xxxxxxxxxxxx xxxx xxxxxxx, xx xxx 16. xxxxxxxxx 2007 xxxx xxxxxxxxxx xxxxxxxxx XXXXXX, xxxxxxxxxxx Xxxxxxxxxxx úmluvy proti xxxxxxx ve sportu¹⁾, xxxxxxxx schválení nového xxxxx Přílohy I - Xxxxxxx xxxxxxxxxx xxxxx x metod xxxxxxx.

Xxxxxxx X xxxxxxxxx x xxxxxxxx x xxxxxxx x článkem 34 xxxx. 3 Úmluvy xxx 1. ledna 2008 a tímto xxxx xxxxxxxxx x xxxxxxxx i xxx Xxxxxx xxxxxxxxx. Xxxx xxxxxx Xxxxxxx I x xxxxxxxx xxxxxxxx xxxxxx Příloha X Xxxxxxxxxxx úmluvy xxxxx xxxxxxx xx xxxxxx xx xxxxx pro xxx 2007, vyhlášená xxx č. 59/2007 Xx. x. x.

Xxxxxxxx znění Xxxxxxx X a její xxxxxxx do českého xxxxxx xx vyhlašují xxxxxxxx.

X1. XXXXXXXXXX XXXXX

Xxxxxxxxxx xxxxx jsou xxxxxxxx.

1. ANDROGENNÍ XXXXXXXXXX XXXXXXXX (XXX):

x. Xxxxxxxx * XXX, xxxxxxxxxx:

1-xxxxxxxxxxxxx (5α-xxxxxxx-1-xx-3β,17β-xxxx); 1-androstendion (5α-xxxxxxx-1-xx-3,17-xxxx); xxxxxxxxx (19-xxxxxxxxxxxxxxxx); xxxxxxxxxx; xxxxxxxx; boldion (xxxxxxxx-1,4-xxxx-3,17-xxxx); xxxxxxx (17α-xxxxxxx-17β-xxxxxxxxxxxxxx-4-xxx[2,3-x]xxxxxxxx); xxxxxxxxxxxxxxxxxxxxxxxxxxxxx (4-xxxxxx-17β-xxxxxxx-17α-xxxxxxxxxxxxx-1,4-xxxx-3-xx); xxxxxxxxxxxxxxxxxxxxxxx (17α-xxxxx-5α-xxxxxxx-2-xx-17β-xx); xxxxxxxxxxx; ethylestrenol (19-nor-17α-pregn-4-en-17-ol); xxxxxxxxxxxxxx; xxxxxxxxxx; xxxxxxxxx (17β-xxxxxxx-17α-xxxxx-5α-xxxxxxxxxx[2,3-x]-xxxxxxx); xxxxxxxxx; 4-hydroxytestosteron (4,17β-xxxxxxxxxxxxxxxx-4-xx-3-xx); xxxxxxxxxx; xxxxxxxxx; xxxxxxxxxx; xxxxxxxxxx; xxxxxxxxxxx (17β-xxxxxxx-17α-xxxxxxxxxxxxx-1,4-xxxx-3-xx); metenolom; xxxxxxxxxxx; xxxxxxxxxx (2α, 17α-xxxxxxx-5α-xxxxxxxxx-3-xx-17β-xx); xxxxxxxxxxxxxx (17β-xxxxxxx-17α-xxxxxxxxxx-4,9-xxxx-3-xx); xxxxxx-1-xxxxxxxxxxx (17β-xxxxxxx-17α-xxxxx-5α-xxxxxxx-1-xx-3-xx); xxxxxxxxxxxxxxxxxxxx (17β-xxxxxxx-17α-xxxxxxxxx-4-xx-3-xx); xxxxxxxxxxxxxxx (17β-xxxxxxx-17α-xxxxxxxxxx-4,9,11-xxxxx-3-xx); xxxxxxxxxxxxxxxxx; xxxxxxxxx; xxxxxxxxx; 19-norandrostendion (xxxx-4-xx-3,17-xxxx); norboleton; norethandrolon; xxxxxxxxxxxx; xxxxxxxx; xxxxxxxxxx; xxxxxxxxxxx; xxxxxxxxxx; prostanozol ([3,2-x]xxxxxxx-5α-xxxxxxxxxxxxxx-17β-xxxxxxxxxxxxxxxxx); xxxxxxxxx; stanozolol; xxxxxxxxx; 1-xxxxxxxxxxx (17β-hydroxy-5α-androst-1-en-3-on); xxxxxxxxxxxxxxxxxxx (18α-homo-pregna-4,9,11-trien-17β-ol-3-on); xxxxxxxxx x xxxxx xxxxx x xxxxxxxx chemickou xxxxxxxxxx xxxx xxxxxxxxx xxxxxxxxxxxx xxxxxx.

b. Xxxxxxxxx ** XXX:

Xxxxxxxxxxxxx (xxxxxxx-5-xx-3β,17β-xxxx), androstendion (xxxxxxx-4-xx-3,17-xxxx), xxxxxxxxxxxxxxxxxx, xxxxxxxxx (xxxxxxxxxxxxxxxxxxxxx, XXXX), testosteron x následující xxxxxxxxxx x isomery:

5α-androstan-3α,17α-diol androst-5-en-3β,17α-diol

5α-xxxxxxxxx-3α,17β-xxxx 4-xxxxxxxxxxxxx (androst-4-en-3β,17β-diol)

5α-androstan-3β,17α-diol 5-androstendion (xxxxxxx-5-xx-3,17-xxxx)

5α-xxxxxxxxx-3β,17β-xxxx xxx-xxxxxxxxxxxxxxxxxx

xxxxxxx-4-xx-3α,17α-xxxx 3α-xxxxxxx-5αxxxxxxxxx-17-xx

xxxxxxx-4-xx-3α,17β-xxxx 3β-xxxxxxx-5αxxxxxxxxx-17-xx

xxxxxxx-5-xx-3β,17α-xxxx 19-xxxxxxxxxxxxxx

xxxxxxx-5-xx-3α,17α-xxxx 19-xxxxxxxxxxxxxxxxx

androst-5-en-3α,17β-diol

X xxxxxxxxx, xxx může xxxx xxxxxxxxxx androgenní xxxxxxxxxx steroid xxxxxxxxx, xxxx xx xxx xx to, xx Xxxxxx xxxxxxxx xxxx Xxxxxxxxx xxxxx x xxxx hlášen xxxxxxxxx Xxxxxxxxx xxxxxxxxxxx xxxxx, xxxx xx xxxxxxxxxxx Xxxxxxxx xxxxx nebo xxxxxx metabolitů nebo xxxxxxxxxxx x/xxxx když xx jakýkoli xxxx xxxxxxxxx xxxxx ve Xxxxxx Xxxxxxxxx xxxxxxxx xxxxxxxxx xx xxxxxxx xxxxxx, xxxxx xx xxxxxxxx vyskytují x xxxx xxx, že xxxxxxxxxx normální xxxxxxxxx xxxxxxxx. Xxxxxx xx xxx xx xx, xx Xxxxxx xxxxxxxx Xxxxxxxxx xxxxx x xxxxxxx xxxxxxx, xxxxx Xxxxxxxxx xxxxxxx, xx xx xxxxxxxxxxx Xxxxxxxx xxxxx xxxx jejích xxxxxxxxxx xxxx xxxxxxxxxx x/xxxx příslušný xxxxx xx Xxxxxx Xxxxxxxxx xxxxxxxx fyziologickým nebo xxxxxxxxxxxx xxxxxx.

Xxxx xx mít za xx, xx Xxxxxx Xxxxxxxxx obsahuje Xxxxxxxxx xxxxx a laboratoř xxxxxxx Xxxxxxxxx xxxxxxxxxxx xxxxx xx xxxxx xxxxxxxxx x xxx xxxxxxxxx xxxxxxxxxxx, xxxxx xxx podle xxxxxxxxxx xxxxxxxxxx metody (např. XXXX) xxxxxxxx, xx xx Xxxxxxxx xxxxx xxxxxxxxxx xxxxxx. V xxxxxxx xxxxxxx není xxxxx xxxxxxxx xxxxx xxxxxxx.

Xxxx xx xxxxxxx xxxxxxxx analýzy xxxxxxxx xxxxxxxxxxx od xxxxxxx xxxxxx, které xx normálně vyskytují x xxxx a xxxxx xxxxxxxxxx xxxxxxxxxx xxxxxx (xxxx. IRMS) xxxxxxxxxxx xxxxxxxx xxxxx Xxxxxxxx xxxxx, xxx xxxxxxxx známky použití Xxxxxxxx xxxxx, xxxx xxxx. xxxxxxxxx x xxxxxxxxxxx referenčními steroidními xxxxxxx, nebo když xxxxxxxxx xxxxxxxxx xxxxx X/X vyšší xxx xxxxx (4) xx xxxxx (1) a xxxxx xxxxxxxxxx xxxxxxxxxx xxxxxx (xxxx. XXXX) xxxxxxxxxxx xxxxxxxx xxxxx xxxxx, xxxxxxx příslušná Xxxxxxxxxxxxx xxxxxxxxxx další xxxxxxx xxxxxxxxxx xxxxxxxx xxxxxxxxxx xxxxx xxxx xxxxxxxxxx následných testů.

Xx-xx xxxxxxxxxx xxxxxx xxxxx xxxxxxx, xxx xxxxxxxx bude xxxxxxxxxx xxxxxx jako neobvyklý x xx xxxx xxxxxxxxx. Xxxxx xxxxxxxxx xxxxxxx, xx xxxxxxx xxxxxxxxxx analytické xxxxxx (xxxx. IRMS) xxxxxxxx xxxxx Xxxxxxxx xxxxx, xxxx nutné xxxxxxxx xxxxx xxxxxxx, x xxxx xx xxx xx xx, xx Xxxxxx xxxxxxxx Xxxxxxxxx xxxxx. Xxxxx nebyla xxxxxxx xxxxxxxxxx xxxxxxxxxx xxxxxx (xxxx. XXXX) x nejsou x xxxxxxxxx xxxxxxxxx 3 xxxxxxxxx testy, xxxx xxxxxxx xxxxxxxxxxxxxx xxxxxx Xxxxxxxxx xxx, xx xxxx příslušnou Xxxxxxxxxxxxxx xxxxxxxxxx x xxxxxxxxxxxxx 3 xxxxxxxx třikrát xxxxxxxx xxx xxxxxxxxxxx xxxxxxxx. Výsledek, xxxxx xxxxxxxxxx xxxx xxxxxxxxxxxxxx xxxxxx, xxxx xxxxxx xxxx xxxxxxxxx. Xxxxx xxxxxxxxxxxxxx xxxxxx Sportovce, xxxxxxxx xxxxxxxxxx testy, xxxx xxxxxxxxxxxx normální, xxxx se pak xxxxxxxxx xx Pozitivní xxxxxxxxxxx xxxxx.

V xxxxxxxx vzácných xxxxxxxxxxxxxx xxxxxxxxx xxxx být x xxxx xxxxxx xxxxxxx xxxxxxxx endogenního xxxxxx ve xxxxxx xxxxxx xxxxxxxxxxxxx (xx/xx). Xxxxx xxxxxxxxx takový xxxxx xxxxxxxxx x xxxxxxx spolehlivé xxxxxxxxxx xxxxxx (xxxx. IRMS) xxxxxxxxxxx xxxxxxxx původ Xxxxxxxx xxxxx, xxxx xxx provedeno xxxxx xxxxxxx provedením xxxxxxxxxx xxxxx (xxxxxxxxxx xxxxx).

Xxxxx xxxxxxxxx xxxxxxxxx Xxxxxxxxx laboratorní xxxxx 19-xxxxxxxxxxxxxxx, bude xx xx xxxxxxxxx xx xxxxxxx x xxxxxxxxxxx xxxxx exogenního xxxxxx Xxxxxxxx xxxxx. V xxxxxxx xxxxxxx xxxx xxxxx provádět xxxxx xxxxxxx.

X xxxxxxx, xx Xxxxxxxxx xxxxxx xxxxxxxxxxxxx xxx dalších xxxxxxxxx, xxxx xx xxx za xx, xx Vzorek Xxxxxxxxx xxxxxxxx Zakázanou xxxxx.

2. Xxxxxxx anabolické xxxxx, xxxxxxxxxx:

Klenbuterol, xxxxxxxxxx xxxxxxxxxx xxxxxxxxxxxxx xxxxxxxxx (XXXX), xxxxxxx, xxxxxxx, xxxxxxxxxx, xxx xx x omezením xxxxx na xx.

X2. XXXXXXX X XXXXXXXX XXXXX

Následující xxxxx x jejich uvolňující xxxxxxx xxxx zakázány:

1. Xxxxxxxxxxxx (XXX);

2. Růstový hormon (xXX), xxxxxxxx podobné xxxxxxx faktory (xxxx. XXX-1), xxxxxxxxxx xxxxxxx xxxxxxx (XXX);

3. Xxxxxxxxxxxxx (např. LH, xXX), zakázané jen x xxxx;

4. Xxxxxxxx;

5. Kortikotropiny

x další xxxxx x xxxxxxxx xxxxxxxxx xxxxxxxxxx xxxx podobnými xxxxxxxxxxxx účinky.

Xxxxx Xxxxxxxxx xxxxxx xxxxxxxx, xx xxxxxxxxxxx xxxx xxxxxxxxx xxxxxxxxxxxxx či xxxxxxxxxxxx xxxxxx, xxxx xx mít xx xx, že Xxxxxx xxxxxxxx Xxxxxxxxx látku (xxx je xxxxxxx xxxx) v případech, xxx xxxxxxxxxxx Zakázané xxxxx nebo jejích xxxxxxxxxx xx xxxxxxxxxx x/xxxx příslušné xxxxxx xx Vzorku Xxxxxxxxx xxxxxxx překročí xxxxxxx xxxxxxxx xxxxxxxx x xxxx tak, xx xxxxxxxxxxxx xxxxxxxx endogenní xxxxxxxx.

Pokud xxxxxxxxx xxxxxxxxx, xx xxxxx xxxxxxxxxx analytické xxxxxx, xx Xxxxxxxx xxxxx xx xxxxxxxxxx xxxxxx, xxxx xx xxx xx to, že Xxxxxx xxxxxxxx Xxxxxxxxx xxxxx a bude xxxxxxx Xxxxxxxxx xxxxxxxxxxx xxxxx.

X3. XXXX-2 AGONISTÉ

Všichni xxxx-2 xxxxxxxx včetně xxxxxx X- x X-xxxxxxx xxxx xxxxxxxx.

Xxxxxxxx xxxx formoterol, xxxxxxxxxx, xxxxxxxxxx a xxxxxxxxxx, pro které xx při inhalaci xxxxx udělení xxxxxxxx xxxxxxxxxxxx xxxxxxx.

I xxxx xxxx udělena xxxxxxxx forma xxxxxxxxxxxx xxxxxxx, bude xxxxx xxxxxxxxxxx (volný xxxx xxxxxxxxxx) vyšší xxx 1000 xxxxxxxxx x 1 xxxxxxxxx xxxx xxxxxxxxx xx Xxxxxxxxx xxxxxxxxxxx nález, xxxxx Xxxxxxxxx xxxxxxxxx, xx xxxxxxxxxx xxxxxxxx xxx xxxxxxxx xxxxxxxxxxxxx užíváním xxxxxxxxxxx x inhalaci.

S4. XXXXXXXXXXX X XXXXXXXXXX XXXXXXX

Xxxxxxxxxxx skupiny xxxx xxxxxxxx:

1. Inhibitory xxxxxxxx, xxxxxxxxxx:

2. Xxxxxxxxxx xxxxxxxxxx xxxxxxxxxxxxx xxxxxxxxx (SERM), xxxxxxxx:

3. Xxxxxxx xxxxxxxxxxxxxx xxxxx xxxxxxxxxx:

4. Xxxxx modifikující xxxxxx xxxxxxxxxx xxxxxx xxxxxxxxxx xxxxxxxxxx, xxx ne x xxxxxxxx pouze xx xx.

X5. DIURETIKA X XXXXXXX XXXXXXXXX LÁTKY

Maskovací xxxxx xxxx xxxxxxxx. Xxxxxxxx:

Xxxxxxxxx*, epitestosteron, xxxxxxxxxx, xxxxxxxxxx xxxx-xxxxxxxxx (xxxx. xxxxxxxxxx, dutasterid), plasmaexpandery (xxxx. xxxxxxx, xxxxxxx, xxxxxxxxxxxxxxxxx) a xxxxx xxxxx x xxxxxxxxx xxxxxxxxxxxx xxxxxx.

Diuretika xxxxxxxx:

Xxxxxxxxxxxx, xxxxxxxx, xxxxxxxxx, furosemid, xxxxxxxxxxxx, xxxxxxxxx, xxxxxxxx, xxxxxxxx xxxxxxxxxx, metolazon, xxxxxxxxxxxxx, xxxxxxxx (xxxx. xxxxxxxxxxxxxxxxxx, xxxxxxxxxxxxxxxxxx, xxxxxxxxxxxxx), xxxxxxxxxx x xxxxx látky x podobnou chemickou xxxxxxxxxx xxxx xxxxxxxxx xxxxxxxxxxxx xxxxxx (xxxxx xxxxxxxxxxxx, xxxxx xxxx xxxxxxxx).

* Xxxxxxxxxxxx xxxxxxx xxxx xxxxxx, xxxxx xxx Xxxxxxxxx xxxxxxxx xxxxxxxxx xx xxxxxxx s prahovou xxxx xxxxxxxxxxx hladinou xxxx Xxxxxxxx xxxxx (xxxxx).

X1. ZVYŠOVÁNÍ XXXXXXX XXXXXXX

Xxxxxxxx je xxxxxxxxxxx:

M2. CHEMICKÁ X XXXXXXXXX XXXXXXXXXX

M3. XXXXXX XXXXXX

Neterapeutické xxxxxxx xxxxx, xxxx, xxxxxxxx elementů, xxxx xxxxxxxxxx xxxxxxx xxxx, xxxxx mají schopnost xxxxxx xxxxxxxxx xxxxx, xx xxxxxxxx.

X6. STIMULANCIA

Všechna xxxxxxxxxxx (xxxxxx obou xxxxxx xxxxxxxxxx xxxxxxxxx (X- x X-) xxxxxxx) jsou zakázaná, x výjimkou derivátů xxxxxxxxx v xxxxxxx xxxxxx xxxxxxxx užití x xxxxxxxxxxx xxxxxxxxxx xx Monitorovacího xxxxxxxx xxx rok 2008.

Xxxxxxxxxxx zahrnují:

Xxxxxxxxx, xxxxxxxxx**, amfepramon, amfetaminil, xxxxxxxxxx, xxxxxxxxx, xxxxxxxxxxx, xxxxxxxxxxxxxxx, xxxxxxxxx, cyklazodon, xxxxxxxxxxxxxxxxx, xxxxxxx****, xxxxxxxx, xxxxxxxxx, xxxxxxxxxxxxxx, xxxxxxxxxxx, xxxxxxxxxxx, fendimetrazin, fenetylin, xxxxxxxxxxx, xxxxxxxxxxx, xxxxxxxx, xxxxxxxxxxx, xxxxxxxxxxxxx, xxxxxxxxxxx, xxxxxxxxx, 4-xxxxxxxxxxxxxx (xxxxxxxx), xxxxxxxxxx, xxxxxxxxxx, xxxxxxxxxxxx, xxxxx***, klobenzorex, kokain, xxxxxxxxxxx, xxxxxxxxxx, xxxxxxxxxxxxxxx, xxxxxxxxx, xxxxxxxxxxx, xxxxxxxxxxxx, xxxxxxxxxxxx (X-), metylefedrin****, xxxxxxxxxxxxxxxxxxxxxx, xxxxxxxxxxxxxxxxxxxxxxxxx, xxxxxxxxxxxxx, xxxxxxxx, modafinil, niketamid, xxxxxxxxxxx, xxxxxxxxxxxxxx, xxxxxxxxx, xxxxxxxxx, xxxxxxxxx, parahydroxyamfetamin, xxxxxxx, pentetrazol, x-xxxxxxxxxxxxxxx, xxxxxxxxx, propylhexedrin, selegilin, xxxxxxxxxx, xxxxxxxxx, tuaminoheptan x xxxxx látky x podobnou xxxxxxxxx xxxxxxxxxx xxxx podobnými xxxxxxxxxxxx xxxxxx.

Xxxxxxxxxxxx xxxxxxxxx xxxxxxxx xxxx xxxxxxxx v xxxxx xxxxxx xxxx xxxxxxxxxx xx xxxxxxxxxxx xxxxx pouze, pokud Xxxxxxxxx prokáže, xx xxxx xxxxxxxxx xxxxxxxxxx x xxxxxxx xxxxxxxxx xxxxxxxxxxx xxxxxxxx neúmyslné xxxxxxxx xxxxxxxxxxxxxxx xxxxxxxx, xxxx xx x xxx xxxxx xxxxxxxxxxxxxxx, xx bude xxxxxxx xxxxxxxx jako xxxxxxxxx xxxxx.

X7. XXXXXXXXX

Xxxxxxxxxxx xxxxxxxxx xxxx xxxxxxxx:

Buprenorfin, xxxxxxxxxxxxx, xxxxxxxxx(xxxxxx), xxxxxxxx x jeho xxxxxxxx, xxxxxxxxxxx, metadon, morfin, xxxxxxxx, xxxxxxxxx, xxxxxxxxxx, xxxxxxx.

X8. XXXXXXXXXXX

Kanabinoidy (xxxx. xxxxx, xxxxxxxxx) xxxx xxxxxxxx.

X9. XXXXXXXXXXXXXXXXXXXX

Xxxxxxx xxxxxxxxxxxxxxxxxxxx xxxxxxxx orálně, xxxxxxxx, xxxxxxxxxx xxxx xxxxxxxxxxxxx xxxxxxxx xxxx zakázané. Xxxxxx užití vyžaduje xxxxxxxxxxxxx výjimku.

Xxxx xxxxxxx injekční xxxxxxxx (xxxxxxxxxxxx, xx okolí xxxxxx, xx okolí xxxxxx, xxxxxxxxxx, xx xxxx) x inhalační xxxxxxxx xxxxxxxx xxxxxxxxx xxxxxxxxxxxxx xxxxxxx s xxxxxxxx níže xxxxxxxxx.

Xxxxxxx xxxxxxxxx xxxxxxxx xx xxxxxx kožní (xxxxxx iontoforézy/fonoforézy), ušní, xxxxx, oční, xxxxxx xxxxx xxxxxxx xxxxxx, xxxxxxxx xxx x xxxxx xxxxxx xxxxxxxx x nevyžadují xxxxxx xxxxx xxxxxxxxxxxx xxxxxxx.

P1. XXXXXXX

Alkohol (xxxxxx) xx xxxxxxxx xxxxx Xxx soutěži v xxxxxxxxxxxxx xxxxxxxx. Xxxxxxx xx xxxx xxxxxxxx xxxxxxxx xxxxxxxx a/nebo xxxxxxxx xxxx. Xxxxxxx xxxxxxx xxx xxxxxxxx xxxxxxxxxxx xxxxxxxx (hematologická xxxxxxx) je xxx xxxxxx federaci xxxxxxx x závorkách.

∙ Xxxxxxxxxxxx sport (XXX) (0.10 x/x)

∙ Xxxxxx (XXX) (0.10 x/x)

∙ Xxxxxxx xxxxxx a xxxxxxxxxxxx (XXX) (0.20 x/x)

∙ Lukostřelba (FITA, XXX) (0.10 g/l)

∙ Moderní xxxxxxx (XXXX) xxx xxx xxxxxxxxxx xx xxxxxxxx (0.10 g/l)

∙ Motocyklový sport (XXX) (0.10 x/x)

∙ Xxxxx motorismus (XXX) (0.30 x/x)

∙ Xxxxxxx (XXX) (0.10 g/l)

X2. XXXX-XXXXXXXXX

Xxxxx xxxx xxxxx xxxxxx, xxxx-xxxxxxxxx jsou xxxxxxxx xxxxx Při xxxxxxx x xxxxxxxxxxxxx xxxxxxxx.

∙ Xxxxxxxxxxxx sport (XXX)

∙ Xxxxxxxx (XXXX)

∙ Boby (XXXX)

∙ Xxxxx (XXX)

∙ Xxxxxxx (XXX)

∙ Xxxxxxxxxx (XXX)

∙ Jachting (XXXX) - "xxxxx xxxx" - xxx xxxxxxxxxxx

∙ Xxxxxxx (XXX)

∙ Letecké xxxxxx a parašutismus (XXX)

∙ Xxxxxxxxxxx (XXXX, IPC) (xxxxxxxx xxxx Mimo xxxxxx)

∙ Xxxxxxxx (XXX) - xxxxx na xxxxxx x xxxxxxxxxxx xxxxxxxx-xxxxx x X-xxxxx, x xxxxxxxxx X-xxxxx x "big xxx"

∙ Xxxxxxx xxxxxxx (XXXX) - xxx xxxxxxxxxx xx xxxxxxxx

∙ Motocyklový sport (XXX)

∙ Petanque x xxxxxxx xxxxxx (XXXX, IPC "bowls")

∙ Xxxxxxx (XXXX, XXX) (xxxxxxxx xxxx Xxxx xxxxxx)

∙ Xxxxx xxxxxxxxxx (XXX)

∙ Xxxxx (XXXX)

Xxxx-xxxxxxxxx zahrnují následující xxxxx:

Xxxxxxxxxx, alprenolol, xxxxxxxx, xxxxxxxxx, bisoprolol, xxxxxxx, xxxxxxxxxx, xxxxxxx, xxxxxxxxx, xxxxxxxxxx, xxxxxxxxx, xxxxxxxxxxx, xxxxxxxxxxxx, xxxxxxxxxx, xxxxxxx, oxprenolol, xxxxxxxx, xxxxxxxxxxx, sotalol, xxxxxxx, xxx xx s xxxxxxxx xxxxx xx xx

"Xxxxxxxxxx xxxxx"* xxxx xxxxxxxxxxx níže:

∙ Xxxxxxx Beta-2 xxxxxxxx v xxxxxxxx, xxxxx xxxxxxxxxxx (volného xxxx xxxxxxxxxxx) xxx xxxxxxxx větším než 1000 xx/xx moči x xxxxxxxxxxxx (xxxxxxx xx xxxxxxx X 1.2 Xxxxxxx xxxxxxxxxx xxxxx);

∙ Inhibitory xxxx-xxxxxxxxx, xxxxxxxxxx;

∙ Xxxxx, xxxxxxxxxxx, krotetamid, xxxxxxx, xxxxxxxx, famprofazon, xxxxxxxxxxxxx, haptaminol, xxxxxxxxxxxx, xxxxxxxxxxxxxxx, meklofenoxát, p-metylamfetamin, xxxxxxxxxxxx, niketamid, xxxxxxxxxxx, xxxxxxxxx, xxxxxxxxx, oxilofrin, xxxxxxxxxxxxxx, selegilin, xxxxxxxxxx, xxxxxxxxxxxxx a xxxxxxx xxxxxxx xxxxxxxxxxx xxxxxxxxx xxxxxxxx x xxxxxx X6, pro xxxxx Xxxxxxxxx xxxxxxx, že xxxxxxx xxxxxxxx popsané x xxxxxx S6;

∙ Kanabinoidy;

∙ Xxxxxxx Xxxxxxxxxxxxxxxxxxxx;

∙ Xxxxxxx;

∙ Xxxxxxx Xxxx-xxxxxxxxx.

*"V Xxxxxxx xxxxx xxx xxxxxxxxxxx xxxxxxxxxx xxxxx, xxxxx xxxxxxxx xxxxxxxx xxxxxxxxx xxxxxxxx xxxxxxxxxxxxxxx xxxxxxxx, xxxxxxx xxxx všeobecně xxxxxxxx v xxxxxxx xxxxxxxxx přípravcích, xxxx x xxxxx xx xxxxx pravděpodobnost, xx xxxxx úspěšně xxxxxxxx xxxx xxxxxxxxx činidla." Xxxxxxxx xxxxxxxxxxxxxxx xxxxxxxx xxxxxxxxxx xxxxxxxx látky xxxx znamenat xxxxxxx xxxxxx xx xxxxxxxxxxx, xx "...Xxxxxxxxx xxxx xxxxx xxxxxxxx, xx Xxxxxxx specifické xxxxx xxxxxx xxxxxxxxx xx xxxxxxx xxxxxxxxxxx xxxxxx...".

Xxxxxx xxxxxxx x. 2/2008 Xx. m. x. nabyl účinnosti xxxx 31.1.2008.

Xxxxxx xxxxxxx x. 2/2008 Sb. x. x. xxx xxxxxx xxxxxxx xxxxxxxxx č. 8/2009 Sb. m. s. x xxxxxxxxx od 7.2.2009.

Znění xxxxxxxxxxxx právních xxxxx xxxxxx právních xxxxxxxx x odkazech xxxx xxxxxxxxxxxxx, pokud se xxxx netýká xxxxxxxxx xxxxx xxxxx xxxxxxxxx xxxxxxxx xxxxxxxx.